Sound Income Strategies, LLC Cti Biopharma Corp Transaction History

Sound Income Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	BUY	$1.44 - $2.86 $28 - $57	20 New	20 $0
Q3 2021 Oct 12, 2021	SELL	$2.25 - $3.18 $74 - $104	-33 Closed	0 $0
Q4 2019 Jan 07, 2020	BUY	$0.72 - $1.64 $23 - $54	33 New	33 $0
Q4 2019 Jan 06, 2020	SELL	$0.72 - $1.64 $23 - $54	-33 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.47 - $3.34 $81 - $110	33	33 $0

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Sound Income Strategies, LLC with notifications on news.